Author

H. Kalofonos

Institutions: University of Patras, Hellenic Cooperative Oncology Group

Observed institutions: University of Patras, General University Hospital of Patras, Hellenic Cooperative Oncology Group

OpenAlex ID: A5083476359

12P Clinical and molecular characteristics of patients with young onset colorectal cancer (YOCRC) in the Greek and Cypriot population: A-retrospective study

2026 · C. Cortas, Z. Saridaki-Zoras, et al. · Annals of Oncology

Abstract PS1-08-08: monarchE: subgroup analysis of adjuvant abemaciclib + endocrine therapy for HR+, HER2-, high-risk early breast cancer by nodal status

2026 · J. Cortes, S. R. D. Johnston, et al. · Clinical Cancer Research

2041eP Higher patras immunotherapy score (PIOS) is associated with improved clinical outcomes in advanced NSCLC under chemoimmunotherapy

2025 · F-I.D. Dimitrakopoulos, P. Christopoulos, et al. · Annals of Oncology

EP08.01-072 Clinical Value of Patras Immunotherapy Score (PIOS) Formula in Patients With Advanced NSCLC Treated With Immunotherapy/Chemotherapy

2022 · F.-I. Dimitrakopoulos, P. Christopoulos, et al. · Journal of Thoracic Oncology

Works count: 4

Citation count:

H-index:

I10-index: